Mylan shares bounce 6% on plans for Botox copycat, 2018 drug launches By: MarketWatch March 01, 2018 at 11:02 AM EST The move allows Mylan to vie for one of rival Allergan’s most valuable assets. Read More >> Related Stocks: AbbVie Allergan Plc Amgen Gsk Plc ADR Mylan Revance Therapeutics